Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Return on Sales (2020 - 2022)

Rapid Therapeutic Science Laboratories' Return on Sales history spans 3 years, with the latest figure at 50974.53% for Q3 2022.

  • For Q3 2022, Return on Sales fell 3930569.0% year-over-year to 50974.53%; the TTM value through Sep 2022 reached 50974.53%, down 5116531.0%, while the annual FY2021 figure was 5370.57%, 535489.0% down from the prior year.
  • Return on Sales for Q3 2022 was 50974.53% at Rapid Therapeutic Science Laboratories, down from 31043.98% in the prior quarter.
  • Across five years, Return on Sales topped out at 4.87% in Q1 2020 and bottomed at 50974.53% in Q3 2022.
  • The 3-year median for Return on Sales is 1263.89% (2021), against an average of 11229.25%.
  • The largest annual shift saw Return on Sales crashed -2637bps in 2021 before it plummeted -3930569bps in 2022.
  • A 3-year view of Return on Sales shows it stood at 41.39% in 2020, then plummeted by -48823bps to 20246.78% in 2021, then crashed by -152bps to 50974.53% in 2022.
  • Per Business Quant, the three most recent readings for RTSL's Return on Sales are 50974.53% (Q3 2022), 31043.98% (Q2 2022), and 7329.38% (Q1 2022).